Literature DB >> 960381

A profile of patients with intractable blepharospasm.

B R Frueh, A Callahan, R K Dortzbach, R B Wilkins, H L Beale, H S Reitman, F R Watson.   

Abstract

Of those patients seeking surgical correction for intractable blepharopasm, the spasm was more commonly bilateral than unilateral by a ratio of about 7:1 and the bilateral form was more common in women than men by a ratio of about 3:1. The unilateral disease had an equal sex incidence. The disease seemed to be the same in men and women. The median age of onset was 59 years old, and the median interval between onset of symptoms and surgery was three years. Most of these patients had seen many physicians, and all prior medical and surgical treatments had been unsuccessful.

Entities:  

Mesh:

Year:  1976        PMID: 960381

Source DB:  PubMed          Journal:  Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol        ISSN: 0161-6978


  3 in total

1.  Botulinum toxin type A therapy for blepharospasm.

Authors:  Gonçalo S Duarte; Filipe B Rodrigues; Raquel E Marques; Mafalda Castelão; Joaquim Ferreira; Cristina Sampaio; Austen P Moore; João Costa
Journal:  Cochrane Database Syst Rev       Date:  2020-11-19

2.  [Idiopathic blepharospasm. Clinical and electrophysiological investigations in 27 patients (author's transl)].

Authors:  E Schenck; D Schmidt
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1978-12-14

3.  Blepharospasm: a case study comparison of trihexyphenidyl (Artane) versus EMG biofeedback.

Authors:  P J Brantley; C L Carnrike; M E Faulstich; C A Barkemeyer
Journal:  Biofeedback Self Regul       Date:  1985-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.